Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs VF Corp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while VF Corp trades at $16.49 (market cap $6.48B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 4.8× VF Corp's market cap, and VF Corp pays the higher dividend (2.18%). Which is the better fit depends on your goals.
| GEHC | VFC | |
|---|---|---|
Market Cap | $30.93B | $6.48B |
Volume | 5,033,451 | 18,946,837 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $21.55 |
52-Week Low | $59.48 | $12.62 |
Enterprise Value | $39.39B | $10.76B |
Dividend Yield | 0.23% | 2.18% |
Typical Hold Time | — | 64 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
VFC trades at $16.07, up 1.77% today, with a bullish technical signal from moving averages despite overbought RSI readings. The company reported mixed quarterly results, beating in Q4 2025 but missing in subsequent quarters, while revenue declined to $9.5B in 2025 with a net loss of $189.72M. Analyst consensus shows a Hold rating with a $18.33 price target, and the company recently announced a $0.09 dividend for September 2026.
VFC presents a turnaround opportunity with discounted valuation metrics (P/S 0.67) and improving cash flow projections for 2026, but faces significant execution risks from Vans brand weakness and high debt levels. The stock's near-term performance hinges on Q3 2026 earnings delivery and sustained outdoor segment growth offsetting core brand challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
